Aethlon Medical, Inc. (AEMD) News
Follow Aethlon Medical, Inc. (AEMD) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 22 public stories across 12 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Aethlon Medical, Oklo, CID HoldCo, Xenon Pharmaceuticals and Moderna: Why These 5 Stocks Are on Investors' Radars Today
Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average rising 0.61% to 51,778.04, the S&P 500 advancing 1.14% to 7,637.76 and the Nasdaq climbing 1.69% to 26,418.29. These are the top stocks
LIVE | Sep 18, 2026, 01:19 AM UTC
M
U.S. pending home sales rise 0.3% in August
U.S. pending home sales increased 0.3% month over month in August after a revised 2.6% decline in July. The reading compared with estimates for a 2.0% increase.
MACRO | Sep 17, 2026, 05:15 PM UTC
M
U.S. stocks rise as jobless claims decline
U.S. equities traded higher Thursday, with the Nasdaq up about 400 points and the S&P 500 and Dow also advancing. Initial jobless claims fell by 10,000 to 196,000 in the second week of September, versus estimates of 208,
MACRO | Sep 17, 2026, 03:42 PM UTC
M
Aethlon Medical to merge with North Immunology; PIPE about $180M
Aethlon Medical announced a definitive agreement to merge with North Immunology via a tax-free, two-step reorganization, supported by an approximately $180 million PIPE expected to fund immediately prior to closing.
EQUITY | Sep 17, 2026, 12:13 PM UTC
M
Aethlon Medical sets NOR-101 Phase 1a start for 1Q 2027
EQUITY | Sep 17, 2026, 10:37 AM UTC
M
Aethlon Medical to merge with North Immunology; ~$180M financing
Aethlon Medical entered a definitive all-stock merger with North Immunology and an oversubscribed private placement of about $180M, expected to fund operations into 2H 2028. Pre-merger Aethlon holders are expected to own
EQUITY | Sep 17, 2026, 10:34 AM UTC
M
Aethlon Medical to merge with North Immunology to advance NOR-101
North Immunology’s lead program, NOR-101, is a half-life extended anti-IL-13 x IL-18 bispecific antibody for atopic dermatitis, targeting both type 2 and non-type 2 inflammation.
EQUITY | Sep 17, 2026, 10:31 AM UTC
L
Aethlon Medical amends employment agreements for James B. Frakes and Steven P. LaRosa
Aethlon Medical amended the employment agreements of CEO/CFO James B. Frakes and Chief Medical Officer Steven P. LaRosa to provide for lump-sum severance and health care continuation payments upon a qualifying change in
REGULATION | Sep 15, 2026, 12:24 PM UTC
M
Aethlon Medical (AEMD) reports Q1 fiscal 2027 results
Aethlon Medical (AEMD) reports Q1 fiscal 2027 results and provides progress on its Hemopurifier® program, according to TradeXchange Newsdesk.
EQUITY | Aug 13, 2026, 08:15 PM UTC
L
AEMD AEMD - Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
AEMD AEMD - Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
EARNINGS | Aug 05, 2026, 12:03 PM UTC
M
AEMD Announces 1-for-5 Reverse Split
AEMD undergoes 1-for-5 reverse stock split
EQUITY | Aug 04, 2026, 09:06 AM UTC
L
AEMD Announces 1-for-5 Reverse Split
AEMD undergoes 1-for-5 reverse stock split
EQUITY | Aug 04, 2026, 12:33 AM UTC
H
AEMD Announces Reverse Stock Split
AEMD implements 1-for-5 reverse stock split
EQUITY | Jul 31, 2026, 12:04 PM UTC
L
Aethlon Medical Prices $4M Follow-On Offering Of 5,633,009 Shares And Warrants At $0.7101 Per Unit
Aethlon Medical, Inc. (NASDAQ: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the pricing of its follow-on offering of 5,633
EQUITY | Jul 06, 2026, 01:27 PM UTC
L
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
Aethlon Medical Announces Pricing of $4.0 Million Follo
EQUITY | Jul 06, 2026, 01:25 PM UTC
L
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Curis (NASDAQ: CRIS ) stock rose 9.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $20.3 million. Humacyte (NASDAQ: HUMA ) shares moved upwards by 5.45% to $0.71. The marke
EQUITY | Jul 01, 2026, 09:05 PM UTC
L
Aethlon Medical shares are trading lower after the company filed a prospectus for a mixed shelf offering.
Aethlon Medical shares are trading lower after the company filed a prospectus for a mixed shelf offering.
EQUITY | Jul 01, 2026, 01:17 PM UTC
L
Aethlon Medical Files Prospectus For Offering Mixed Shelf
Aethlon Medical Files Prospectus For Offering Mixed Shelf
EQUITY | Jul 01, 2026, 12:49 PM UTC
L
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Alzamend Neuro (NASDAQ: ALZN ) stock increased by 12.9% to $1.35 during Tuesday's after-market session. The company's market cap stands at $4.4 million. Vivos Therapeutics (NASDAQ: VVOS ) shares increased by 9.92
GEOPOLITICS | Jun 30, 2026, 09:05 PM UTC
M
AEMD Publishes Long COVID Biomarker
Aethlon Medical announces publication demonstrating novel long COVID biomarker and potential therapeutic target for the Hemopurifier
EQUITY | Jun 26, 2026, 12:01 PM UTC
M
Healthcare Stocks Moving
Multiple healthcare stocks are moving in Monday's intraday session, with gainers including Tenon Medical and Aditxt, and losers including Aethlon Medical and Atlantic International
EQUITY | Jun 22, 2026, 05:23 PM UTC
L
AEMD Files S-1
AEMD files Form S-1 for up to 6,000,000 shares of common stock
EQUITY | Jun 22, 2026, 01:18 PM UTC